Thursday, January 20, 2022
News
NEWS HOME
COVAXIN
 

Covishield, Covaxin cleared for regular market approval

New Delhi |Thursday, 2022 5:15:07 AM IST
India's two main vaccines -- Bharat Biotechs Covaxin and Serum Institute of India's Covishield -- on Wednesday got the nod for regular market authorisation.... read..
 

SEC recommends regular market approval to Covaxin, Covishield for adults

By Shalini Bhardwaj

New Delhi | January 19, 2022 11:20:58 PM IST
The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult popul... read..
 

Ensure only Covaxin is given to 15-18 group: Bharat Biotech

Hyderabad |Wednesday, 2022 2:45:07 AM IST
Bharat Biotech has urged healthcare workers to ensure that only Covaxin is administered to individuals in the 15-18 years age group.... read..
 

COVID-19: Bharat Biotech requests healthcare workers to ensure only COVAXIN is administered to 15-18 age group

New Delhi | January 18, 2022 10:50:27 PM IST
Following reports of unapproved COVID vaccines being given to 15-18 year age group, Bharat Biotech on Tuesday requested healthcare workers to ensure that only COVAXIN is administered to individuals of the group.... read..
 

SEC asks for more data to grant full market approval to Covaxin and Covishield

New Delhi | January 14, 2022 11:20:29 PM IST
The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources tol... read..
 

DCGI's SEC to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today: Sources

By Shalini Bhardwaj

New Delhi | January 14, 2022 12:50:28 PM IST
Drugs Controller General of India (DCGI)'s Subject Expert Committee will review applications of Bharat Biotech and Serum Institute of India (SII) for full market approval to Covaxin and Covishield respectively on Friday, sources said.... read..
 

COVID-19 vaccine Covaxin now universal vaccine for adults, children: Bharat Biotech

New Delhi | January 14, 2022 12:50:06 AM IST
Hyderabad-based vaccine manufacturer Bharat Biotech on Thursday announced that its indigenously developed COVID-19 vaccine Coavaxin is now a universal vaccine for adults and children.... read..
 

Covaxin can neutralise Delta, Omicron variants of coronavirus: Bharat Biotech

New Delhi | January 12, 2022 8:20:53 PM IST
Hyderabad-based Bharat Biotech on Wednesday claimed that its COVID vaccine Covaxin can neutralise both Delta and Omicron variants of coronavirus.... read..
 

COVID-19: Third Covaxin dose holds promise, says ICMR as India prepares to administer 'precaution' doses from tomorrow

New Delhi | January 9, 2022 8:50:30 PM IST
The third dose of Covaxin holds promise, the Indian Council of Medical Research said on Sunday just a day before the government plans to administer 'precaution' doses of COVID-19 vaccines to frontline workers, healthcare workers and senior citizens with c... read..
 

Covaxin booster dose trial shows 'long-term safety': Bharat Biotech

New Delhi |Sunday, 2022 3:15:07 AM IST
Hyderabad-based vaccine manufacturer Bharat Biotech said on Saturday that its trials for Covaxin booster dose have shown 'long-term safety with no serious adverse events'.... read..
 

COVID-19: Bharat Biotech urges healthcare workers to ensure administration of only Covaxin to 15-18 years agegroup

Hyderabad (Telangana) | January 8, 2022 2:20:41 AM IST
Hyderabad-based vaccine manufacturer Bharat Biotech on Friday said that it has received reports of COVID-19 vaccines other than Covaxin are being administered in children of age group 15-18 years in the country and urged healthcare workers to ensure admin... read..
 

Paracetamol not recommended after getting Covaxin jab: Bharat Biotech

Hyderabad |Thursday, 2022 3:45:08 AM IST
Vaccine maker Bharat Biotech on Wednesday clarified that Paracetamol or pain killers are not recommended for teenagers after being vaccinated with Covaxin.... read..
 

No paracetamol or pain killers are recommended after being vaccinated with Covaxin: Bharat Biotech

New Delhi | January 5, 2022 7:49:58 PM IST
Hyderabad-based vaccine manufacturer Bharat Biotech on Wednesday said that no paracetamol or pain killers are recommended after being vaccinated with COVID-19 vaccine Covaxin.... read..
 

COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan

New Delhi | January 3, 2022 1:20:45 PM IST
Bharat Biotech on Monday informed that India has supplied another batch of humanitarian assistance consisting of 5,00,000 doses of COVID-19 vaccine, Covaxin to Afghanistan.... read..
 

33.2 lakh students in TN to be given Covaxin from Jan 3

Chennai |Saturday, 2022 4:15:08 PM IST
Tamil Nadu health department will be inoculating 33.2 lakh students with Covaxin from January 3 onwards.... read..
 

India supplies 5 lakh Covaxin doses to Afghanistan

New Delhi |Saturday, 2022 9:15:08 PM IST
India supplied humanitarian assistance consisting of 5,00,000 Covaxin doses to Afghanistan on Saturday, the Ministry of External Affairs said.... read..
 

Covaxin for children proven to be safe in paediatric subjects in study: Bharat Biotech

New Delhi |Friday, 2021 2:15:08 AM IST
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that BBV152 (Covaxin), its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.... read..
 

Allow COVAXIN to get in the game: Tennis star Connors urges US to approve India's indigenously-developed COVID vaccine

Washinton | December 31, 2021 8:49:55 AM IST
As the US continues to register a record number of COVID-19 cases, American tennis legend Jimmy Connors has called on the Biden government and country's regulatory authority to recognise India's indigenously developed coronavirus vaccine COVAXIN for its v... read..
 

COVID-19: Himachal receives 2.80 lakh COVAXIN doses to vaccinate 15-18 age group from Jan 3

Shimla (Himachal Pradesh) | December 30, 2021 9:50:00 AM IST
Himachal Pradesh government had received 2.80 lakh COVID-19 vaccine COVAXIN doses to vaccinate its young population of 15-18 age group from January 3.... read..
 

Covaxin found to be safe, immunogenic in 2-18 age group in phase 2, 3 study: Bharat Biotech

By Shalini Bhardwaj

Hyderabad (Telangana) | December 30, 2021 8:19:57 PM IST
Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.... read..
 

Only Covaxin to be administered to children aged 15-18 yrs

New Delhi |Tuesday, 2021 3:15:08 AM IST
As the vaccination process for the teens aged 15 to 18 years will commence from January 3 across the nation, the government has said only Covaxin will be administered.... read..
 

COVID-19 vaccine: 15-18 age group to get Covaxin from Jan 3

New Delhi | December 28, 2021 3:19:55 PM IST
Children aged between 15 to 18 who are eligible for vaccination from January 3 next year will only be administered doses of the Covaxin COVID-19 vaccine, sources in the Union Health Ministry said on Tuesday.... read..
 

Covaxin has shown good immune response in children during trials, says Dr NK Arora

By Shalini Bhardwaj

New Delhi | December 27, 2021 1:49:31 AM IST
Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.... read..
 

Covaxin has shown good immune response in children during trials, says Dr NK Arora

New Delhi | December 26, 2021 11:49:12 PM IST
Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora said on Sunday.... read..
 

Covaxin has shown good immune response in children during trials, says NTAGI chief

New Delhi | December 26, 2021 11:19:46 PM IST
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.... read..
 

Proven record for safety, says Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 yrs

New Delhi | December 25, 2021 11:21:02 PM IST
Covaxin has a proven record for safety and efficacy from all the variants of COVID-19, said Bharat Biotech after its vaccine received emergency usage approval from the Drugs Controller General of India (DCGI) for kids aged between 12-18 years.... read..
 

Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids above 12 yrs

New Delhi | December 25, 2021 9:50:31 PM IST
Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.... read..
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
'Assam on track to become Har Ghar Jal s...
Vikassheel Insaan Party backs Nitish Kum...
Tamil Nadu: Anti-corruption body raids a...
Assam CM launches programs to curb wildl...
Flight operations at Delhi airport norma...
'Output not suffered in work from home, ...
More...    
 
 Top Stories
Danielle Panabaker expecting second... 
Police apprehend three CCLs for mur... 
After Mammootty, Dulquer Salmaan te... 
Sui Wonders joins cast of 'City on ... 
Mumbai civic body references Deepik... 
Hindustan Unilever Q3 profit rises ... 
Upahaar evidence tampering case: Vi... 
Roger Michell's documentary on Quee...